Results 231 to 240 of about 73,286 (248)

Oteseconazole: An Advance in Treatment of Recurrent Vulvovaginal Candidiasis

Future Microbiology, 2021
Paul Nyirjesy, Jack Sobel
exaly  

Risk factors for recurrent vulvovaginal candidiasis in women receiving maintenance antifungal therapy: Results of a prospective cohort study

American Journal of Obstetrics and Gynecology, 2004
Paul Nyirjesy, Foxman Betsy, Jack Sobel
exaly  

Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations

American Journal of Obstetrics and Gynecology, 1998
Paul Nyirjesy, William Ledger, Foxman Betsy   +2 more
exaly  

Vulvovaginal candidiasis

2016
openaire   +2 more sources

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

American Journal of Obstetrics and Gynecology, 1985
Jack Sobel
exaly  

Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2009
Asad U Khan, Anis Ahmad
exaly  

Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2013
Maria I. Rosa, Kristian Madeira
exaly  

Prevalence of , and in pregnant women suffering from vulvovaginal candidiasis in Argentina

Revista Iberoamericana De Micologia, 2017
Maria Teresa Mujica
exaly  

VULVOVAGINAL CANDIDIASIS

InPharma, 1977
openaire   +1 more source

HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-κB activation

International Immunopharmacology, 2012
Kyung-Ah Kim, Dong-Hyun Kim, Young-Tae Ahn   +2 more
exaly